PHYTOCHEMICAL MODULATION OF THE L-ARGININE–ARGINASE–NITRIC OXIDE AXIS IN DIABETES AND INSULIN RESISTANCE
DOI:
https://doi.org/10.46991/PYSUB.2026.60.3.171Keywords:
type 2 diabetes mellitus, insulin resistance, L-arginine, arginase, nitric oxide, nitric oxide synthase, phytochemicals, emodin, quercetin, pseudohypericin, oxidative stressAbstract
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, pro-gressive pancreatic β-cell dysfunction, oxidative stress, chronic inflammation, and vascular complications. Growing evidence suggests that alterations in L-arginine metabolism contribute to diabetes-associated metabolic and vascular dysfunction through interactions between arginase and nitric oxide synthase (NOS). Increased arginase activity and impaired endothelial NOS function may compromise nitric oxide (NO) bioavailability and endothelial homeostasis, whereas inflammation-associated induction of inducible NOS can contribute to nitrosative stress and cellular injury. These alterations highlight the potential involvement of the L-arginine–arginase–NO axis in the pathophysiology of diabetes and insulin resistance. Phytochemicals have attracted attention as multi-target bioactive compounds capable of influencing metabolic, oxidative, and inflammatory pathways. This review examines the potential effects of emodin, quercetin, pseudo-hypericin and other Hypericum-derived constituents, resveratrol, curcumin, and Rumex obtusifolius on L-arginine metabolism and related signaling mechanisms. Particular attention is given to the interplay between arginase–NOS regulation, PI3K/Akt and AMPK signaling, oxidative stress, and inflammatory responses, while distinguishing direct experimental evidence from indirect mechanistic associations. Findings from pharmacological arginase inhibition are also considered to provide mechanistic context. Although phytochemicals may influence this interconnected network, direct evidence of their effects on arginase–NOS regulation remains limited for several compounds, highlighting the need for further mechanistic investigations in diabetes and insulin resistance.
Downloads
References
Ren Y., Li Z., et al. Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications. Oxid. Med. Cell. Longev. 2022 (2022), 2419412. https://doi.org/10.1155/2022/2419412
Martin K.R. Dietary Supplementation with L-Arginine, Single Nucleotide Polymorphisms of Arginase 1 and 2, and Plasma l-Arginine. The Journal of Nutrition 151 (2021), 745–746. https://doi.org/10.1093/jn/nxaa431
Gajecki D., Gawryś J., et al. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus. Nutrients 13 (2021), 2306. https://doi.org/10.3390/nu13072306
Zhou Z., Mahdi A., et al. Erythrocytes from Patients with Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I. Journal of the American College of Cardiology 72 (2018), 769–780. https://doi.org/10.1016/j.jacc.2018.05.052
Tengbom J., Kontidou E., et al. Differences in Endothelial Function between Patients with Type 1 and Type 2 Diabetes: Effects of Red Blood Cells and Arginase. Clinical Science 138 (2024), 975–985. https://doi.org/doi:10.1042/CS20240447
Javrushyan H., Nadiryan E., et al. Antihyperglycemic Activity of L-Norvaline and L-Arginine in High-Fat Diet and Streptozotocin-Treated Male Rats. Experimental and Molecular Pathology 126 (2022), 104763. https://doi.org/10.1016/j.yexmp.2022.104763
Cheng L., Zhang S., et al. Emodin Improves Glucose and Lipid Metabolism Disorders in Obese Mice via Activating Brown Adipose Tissue and Inducing Browning of White Adipose Tissue. Front. Endocrinol. 12 (2021), 618037. https://doi.org/10.3389/fendo.2021.618037
Abdou H.M., Hamaad F.A., et al. Antidiabetic Efficacy of Trifolium alexandrinum Extracts Hesperetin and Quercetin in Ameliorating Carbohydrate Metabolism and Activating IR and AMPK Signaling in the Pancreatic Tissues of Diabetic Rats. Biomedicine & Pharmacotherapy 149 (2022), 112838. https://doi.org/10.1016/j.biopha.2022.112838
Nasrollahi Z., Shahani Pour K., et al. Effect of Quercetin and Abelmoschus Esculentus (L.) Moench on Lipids Metabolism and Blood Glucose through AMPK‐α in Diabetic Rats (HFD/STZ). Journal of Food Biochemistry 46 (2022), e14506. https://doi.org/10.1111/jfbc.14506
Ginovyan M., Javrushyan H., et al. Anti-Cancer Effect of Rumex obtusifolius in Combination with Arginase/Nitric Oxide Synthase Inhibitors via Downregulation of Oxidative Stress, Inflammation, and Polyamine Synthesis. The International Journal of Biochemistry & Cell Biology 158 (2023), 106396. https://doi.org/10.1016/j.biocel.2023.106396
Nadiryan E.E., Hovhannisyan S.M., et al. Regulatory Effects of Rumex obtusifolius and Hypericum alpestre Extracts on the Quantity of IL-2 in in vitro and in vivo Cancer Models. Proc. YSU B: Chem. Biol. Sci. 57 (2023), 248–257. https://doi.org/10.46991/PYSU:B/2023.57.3.248
Ginovyan M., Javrushyan H., et al. Hypericum alpestre Extract Exhibits in vitro and in vivo Anticancer Properties by Regulating the Cellular Antioxidant System and Metabolic Pathway of L‐arginine. Cell Biochemistry & Function 42 (2024), e3914. ttps://doi.org/10.1002/cbf.3914
Heuser S.K., Li J., et al. Biochemistry, Pharmacology, and in vivo Function of Arginases. Pharmacological Reviews 77 (2025), 100015. https://doi.org/10.1124/pharmrev.124.001271
Wu G., Morris S.M. Arginine Metabolism: Nitric Oxide and Beyond. Biochemical Journal 336 (1998), 1–17. https://doi.org/10.1042/bj3360001
Li H., Meininger C.J., et al. Regulatory Role of Arginase I and II in Nitric Oxide, Polyamine, and Proline Syntheses in Endothelial Cells. American Journal of Physiology-Endocrinology and Metabolism 280 (2001), E75–E82. https://doi.org/10.1152/ajpendo.2001.280.1.E75
Durante W. Role of Arginase in Vessel Wall Remodeling. Front. Immunol. 4 (2013). https://doi.org/10.3389/fimmu.2013.00111
Shosha E., Fouda A.Y., et al. Endothelial Arginase 2 Mediates Retinal Ischemia/Reperfusion Injury by Inducing Mitochondrial Dysfunction. Molecular Metabolism 53 (2021), 101273. https://doi.org/10.1016/j.molmet.2021.101273
Zhang Y., Higgins C.B., et al. Hierarchical Tricarboxylic Acid Cycle Regulation by Hepatocyte Arginase 2 Links the Urea Cycle to Oxidative Metabolism. Cell Metabolism 36 (2024), 2069–2085.e8. https://doi.org/10.1016/j.cmet.2024.07.007
Zhang Y., Higgins C.B., et al. Hepatic Arginase 2 (Arg2) is Sufficient to Convey the Therapeutic Metabolic Effects of Fasting. Nat. Commun. 10 (2019), 1587. https://doi.org/10.1038/s41467-019-09642-8
Roy R., Wilcox J., et al. Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardio-vascular Disease: Mechanisms and Therapeutic Potential. IJMS 24 (2023), 15200. https://doi.org/10.3390/ijms242015200
Mattila J.T., Thomas A.C. Nitric Oxide Synthase: Non-Canonical Expression Patterns. Front. Immunol. 5 (2014). https://doi.org/10.3389/fimmu.2014.00478
Farahani A., Farahani A., et al. Inducible Nitric Oxide Synthase (iNOS): More than an Inducible Enzyme? Rethinking the Classification of NOS Isoforms. Pharmacological Research 216 (2025), 107781. https://doi.org/10.1016/j.phrs.2025.107781
Förstermann U., Li H. Therapeutic Effect of Enhancing Endothelial Nitric Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling: Prevention of eNOS Uncoupling. British Journal of Pharmacology 164 (2011), 213–223. https://doi.org/10.1111/j.1476-5381.2010.01196.x
Chen F., Lucas R., Fulton D. The Subcellular Compartmentalization of Arginine Metabolizing Enzymes and Their Role in Endothelial Dysfunction. Front. Immunol. 4 (2013). https://doi.org/10.3389/fimmu.2013.00184
Momma T.Y., Ottaviani J.I. There Is No Direct Competition between Arginase and Nitric Oxide Synthase for the Common Substrate L-Arginine. Nitric Oxide 129 (2022), 16–24. https://doi.org/10.1016/j.niox.2022.09.002
Dioguardi F.S. To Give or Not to Give? Lessons from the Arginine Paradox. Lifestyle Genomics 4 (2011), 90–98. https://doi.org/10.1159/000327777
Shin S., Mohan S., Fung H.-L. Intracellular L-Arginine Concentration Does Not Determine NO Production in Endothelial Cells: Implications on the "l-Arginine Paradox.” Biochemical and Biophysical Research Communications 414 (2011), 660–663. https://doi.org/10.1016/j.bbrc.2011.09.112
Mori M. Regulation of Nitric Oxide Synthesis and Apoptosis by Arginase and Arginine Recycling. The Journal of Nutrition 137 (2007), 1616S-1620S. https://doi.org/10.1093/jn/137.6.1616S
Hoang H.H., Padgham S.V., Meininger C.J. L-Arginine, Tetrahydrobiopterin, Nitric Oxide and Diabetes. Current Opinion in Clinical Nutrition and Metabolic Care 16 (2013), 76–82. https://doi.org/10.1097/MCO.0b013e32835ad1ef
Janaszak-Jasiecka A., Płoska A., et al. Endothelial Dysfunction Due to eNOS Uncoupling: Molecular Mechanisms as Potential Therapeutic Targets. Cell Mol. Biol. Lett. 28 (2023), 21. https://doi.org/10.1186/s11658-023-00423-2
Romero M.J., Platt D.H., et al. Diabetes-Induced Coronary Vascular Dysfunction Involves Increased Arginase Activity. Circulation Research 102 (2008), 95–102. https://doi.org/10.1161/CIRCRESAHA.107.155028
Grönros J., Jung C., et al. Arginase Inhibition Restores in vivo Coronary Microvascular Function in Type 2 Diabetic Rats. American Journal of Physiology-Heart and Circulatory Physiology 300 (2011), H1174–H1181. https://doi.org/10.1152/ajpheart.00560.2010
Kim J., Montagnani M., et al. Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms. Circulation 113 (2006), 1888–1904. https://doi.org/10.1161/CIRCULATIONAHA.105.563213
Baron A.D., Clark M.G. Role of Blood Flow in the Regulation of Muscle Glucose Uptake. Annu. Rev. Nutr. 17 (1997), 487–499. https://doi.org/10.1146/annurev.nutr.17.1.487
Vincent M.A., Barrett E.J., et al. Inhibiting NOS Blocks Microvascular Recruitment and Blunts Muscle Glucose Uptake in Response to Insulin. American Journal of Physiology-Endocrinology and Metabolism 285 (2003), E123–E129. https://doi.org/10.1152/ajpendo.00021.2003
Liu Z., Liu J., et al. Infusing Lipid Raises Plasma Free Fatty Acids and Induces Insulin Resistance in Muscle Microvasculature. J. Clin. Endocrinol. Metab. 94 (2009), 3543–3549. https://doi.org/10.1210/jc.2009-0027
Corbett J.A., Wang J.L., et al. Interleukin 1 Beta Induces the Formation of Nitric Oxide by Beta-Cells Purified from Rodent Islets of Langerhans. Evidence for the Beta-Cell as a Source and Site of Action of Nitric Oxide. J. Clin. Invest. 90 (1992), 2384–2391. https://doi.org/10.1172/JCI116129
Zumsteg U., Frigerio S., Holländer G.A. Nitric Oxide Production and Fas Surface Expression Mediate Two Independent Pathways of Cytokine-Induced Murine Beta-Cell Damage. Diabetes 49 (2000), 39–47. https://doi.org/10.2337/diabetes.49.1.39
Shemyakin A., Kövamees O., et al. Arginase Inhibition Improves Endothelial Function in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus. Circulation 126 (2012), 2943–2950. https://doi.org/10.1161/CIRCULATIONAHA.112.140335.
Cieślak M., Wojtczak A., Cieślak M. Role of Pro-Inflammatory Cytokines of Pancreatic Islets and Prospects of Elaboration of New Methods for the Diabetes Treatment. Acta Biochim. Pol. 62 (2015), 15–21. https://doi.org/10.18388/abp.2014_853
Ming X.-F., Rajapakse A.G., et al. Inhibition of S6K1 Accounts Partially for the Anti-Inflam-matory Effects of the Arginase Inhibitor L-Norvaline. BMC Cardiovasc. Disord. 9 (2009), 12. https://doi.org/10.1186/1471-2261-9-12
Kunz H.E., Hart C.R., et al. Adipose Tissue Macrophage Populations and Inflammation are Associated with Systemic Inflammation and Insulin Resistance in Obesity. American Journal of Physiology-Endocrinology and Metabolism 321 (2021), E105–E121. https://doi.org/10.1152/ajpendo.00070.2021
Saas P., Chagué C., et al. Toward the Characterization of Human Pro-Resolving Macrophages? Front. Immunol. 11 (2020), 593300. https://doi.org/10.3389/fimmu.2020.593300
Novelli M., Masiello P., et al. Protective Role of St. John’s Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from in vitro and in vivo Studies. IJMS 21 (2020), 8108. https://doi.org/10.3390/ijms21218108
Woo A., Min B., Ryoo S. Piceatannol-3’-O-β- D -Glucopyranoside as an Active Component of Rhubarb Activates Endothelial Nitric Oxide Synthase through Inhibition of Arginase Activity. Exp. Mol. Med. 42 (2010), 524–532. https://doi.org/10.3858/emm.2010.42.7.053
Garate-Carrillo A., Navarrete-Yañez V., et al. Arginase Inhibition by (−)-Epicatechin Reverses Endothelial Cell Aging. European Journal of Pharmacology 885 (2020), 173442. https://doi.org/10.1016/j.ejphar.2020.173442
Feng Y., Huang S., et al. Emodin, a Natural Product, Selectively Inhibits 11β‐hydroxysteroid Dehydrogenase Type 1 and Ameliorates Metabolic Disorder in Diet‐induced Obese Mice. British J. Pharmacology 161 (2010), 113–126. https://doi.org/10.1111/j.1476-5381.2010.00826.x
Song P., Kim J.H., et al. Emodin Regulates Glucose Utilization by Activating AMP-Activated Protein Kinase*. Journal of Biological Chemistry 288 (2013), 5732–5742. https://doi.org/10.1074/jbc.M112.441477
Li Y., Li Q., et al. The Effect and Mechanism of Emodin on the NO Secretion of Human Umbilical Vein Endothelial Cells (HUVECs) Induced by High Glucose. International Journal of Endocrinology 2020 (2020), 1–5. https://doi.org/10.1155/2020/4832840
Tribolo S., Lodi F., et al. Human Metabolic Transformation of Quercetin Blocks Its Capacity to Decrease Endothelial Nitric Oxide Synthase (eNOS) Expression and Endothelin-1 Secretion by Human Endothelial Cells. J. Agric. Food Chem. 61 (2013), 8589–8596. https://doi.org/10.1021/jf402511c
Martins-Perles J.V.C., Bossolani G.D.P., et al. Quercetin Increases Bioavailability of Nitric Oxide in the Jejunum of Euglycemic and Diabetic Rats and Induces Neuronal Plasticity in the Myenteric Plexus. Autonomic Neuroscience 227 (2020), 102675. https://doi.org/10.1016/j.autneu.2020.102675
Olabiyi A.A., Tope‐Eniola O.S., et al. Quercetin Boosts Nitric Oxide Levels and Modulates the Activities of Arginase, Acetylcholinesterase and Adenosine Deaminase in the Corpus Cavernosum of Cyclosporine‐Treated Rats. Andrologia 54 (2022). https://doi.org/10.1111/and.14404
Timmers S., Hesselink M.K.C., Schrauwen P. Therapeutic Potential of Resveratrol in Obesity and Type 2 Diabetes: New Avenues for Health Benefits? Annals of the New York Academy of Sciences 1290 (2013), 83–89. https://doi.org/10.1111/nyas.12185
De Ligt M., Bergman M., et al. No Effect of Resveratrol Supplementation after 6 Months on Insulin Sensitivity in Overweight Adults: A Randomized Trial. The American Journal of Clinical Nutrition 112 (2020), 1029–1038. https://doi.org/10.1093/ajcn/nqaa125
Liu K., Zhou R., et al. Effect of Resveratrol on Glucose Control and Insulin Sensitivity: A Meta-Analysis of 11 Randomized Controlled Trials. The American Journal of Clinical Nutrition 99 (2014), 1510–1519. https://doi.org/10.3945/ajcn.113.082024
Klinge C.M., Wickramasinghe N.S., et al. Resveratrol Stimulates Nitric Oxide Production by Increasing Estrogen Receptor α‐Src‐caveolin‐1 Interaction and Phosphorylation in Human Umbilical Vein Endothelial Cells. The FASEB Journal 22 (2008), 2185–2197. https://doi.org/10.1096/fj.07-103366
Chuengsamarn S., Rattanamongkolgul S., et al. Curcumin Extract for Prevention of Type 2 Diabetes. Diabetes Care 35 (2012), 2121–2127. https://doi.org/10.2337/dc12-0116
Bateni Z., Rahimi H.R., et al. The Effects of Nano‐curcumin Supplementation on Glycemic Control, Blood Pressure, Lipid Profile, and Insulin Resistance in Patients with the Metabolic Syndrome: A Randomized, Double‐blind Clinical Trial. Phytotherapy Research 35 (2021), 3945–3953.
https://doi.org/10.1002/ptr.7109
Avtandilyan N., Javrushyan H., et al. The Involvement of Arginase and Nitric Oxide Synthase in Breast Cancer Development: Arginase and NO Synthase as Therapeutic Targets in Cancer. BioMed Research International 2018 (2018), 1–9. https://doi.org/10.1155/2018/8696923
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Proceedings of the YSU

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.